SLEEP NUMBER CORP (SNBR) Stock Fundamental Analysis

NASDAQ:SNBR • US83125X1037

8.58 USD
-0.45 (-4.98%)
Last: Feb 18, 2026, 10:52 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to SNBR. SNBR was compared to 121 industry peers in the Specialty Retail industry. SNBR has a bad profitability rating. Also its financial health evaluation is rather negative. SNBR does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • SNBR had negative earnings in the past year.
  • In the past year SNBR has reported a negative cash flow from operations.
  • The reported net income has been mixed in the past 5 years: SNBR reported negative net income in multiple years.
  • SNBR had a positive operating cash flow in 4 of the past 5 years.
SNBR Yearly Net Income VS EBIT VS OCF VS FCFSNBR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

1.2 Ratios

  • SNBR has a worse Return On Assets (-10.42%) than 73.55% of its industry peers.
  • The Return On Invested Capital of SNBR (3.59%) is comparable to the rest of the industry.
  • The Average Return On Invested Capital over the past 3 years for SNBR is below the industry average of 12.08%.
  • The 3 year average ROIC (7.69%) for SNBR is well above the current ROIC(3.59%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -10.42%
ROE N/A
ROIC 3.59%
ROA(3y)-0.04%
ROA(5y)6.8%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)7.69%
ROIC(5y)19.87%
SNBR Yearly ROA, ROE, ROICSNBR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 -60

1.3 Margins

  • SNBR has a Operating Margin of 1.35%. This is comparable to the rest of the industry: SNBR outperforms 45.45% of its industry peers.
  • SNBR's Operating Margin has declined in the last couple of years.
  • With an excellent Gross Margin value of 60.05%, SNBR belongs to the best of the industry, outperforming 88.43% of the companies in the same industry.
  • SNBR's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 1.35%
PM (TTM) N/A
GM 60.05%
OM growth 3Y-34.99%
OM growth 5Y-18.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.42%
GM growth 5Y-0.76%
SNBR Yearly Profit, Operating, Gross MarginsSNBR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. Health

2.1 Basic Checks

  • SNBR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, SNBR has more shares outstanding
  • Compared to 5 years ago, SNBR has less shares outstanding
  • The debt/assets ratio for SNBR is higher compared to a year ago.
SNBR Yearly Shares OutstandingSNBR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
SNBR Yearly Total Debt VS Total AssetsSNBR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • SNBR has an Altman-Z score of -0.09. This is a bad value and indicates that SNBR is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -0.09, SNBR is doing worse than 76.86% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.09
ROIC/WACC0.4
WACC9.05%
SNBR Yearly LT Debt VS Equity VS FCFSNBR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

2.3 Liquidity

  • A Current Ratio of 0.19 indicates that SNBR may have some problems paying its short term obligations.
  • The Current ratio of SNBR (0.19) is worse than 96.69% of its industry peers.
  • A Quick Ratio of 0.09 indicates that SNBR may have some problems paying its short term obligations.
  • The Quick ratio of SNBR (0.09) is worse than 95.87% of its industry peers.
Industry RankSector Rank
Current Ratio 0.19
Quick Ratio 0.09
SNBR Yearly Current Assets VS Current LiabilitesSNBR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • SNBR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -88.40%.
  • The Revenue for SNBR has decreased by -16.95% in the past year. This is quite bad
  • Measured over the past years, SNBR shows a decrease in Revenue. The Revenue has been decreasing by -0.19% on average per year.
EPS 1Y (TTM)-88.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1135.71%
Revenue 1Y (TTM)-16.95%
Revenue growth 3Y-8.34%
Revenue growth 5Y-0.19%
Sales Q2Q%-19.63%

3.2 Future

  • Based on estimates for the next years, SNBR will show a very strong growth in Earnings Per Share. The EPS will grow by 34.93% on average per year.
  • SNBR is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -3.38% yearly.
EPS Next Y-326.51%
EPS Next 2Y20.66%
EPS Next 3Y33.72%
EPS Next 5Y34.93%
Revenue Next Year-17.81%
Revenue Next 2Y-10.21%
Revenue Next 3Y-5.39%
Revenue Next 5Y-3.38%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SNBR Yearly Revenue VS EstimatesSNBR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B
SNBR Yearly EPS VS EstimatesSNBR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 -2 4 6

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • SNBR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SNBR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SNBR Price Earnings VS Forward Price EarningsSNBR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

  • 96.69% of the companies in the same industry are more expensive than SNBR, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 2.62
SNBR Per share dataSNBR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60

4.3 Compensation for Growth

  • SNBR's earnings are expected to grow with 33.72% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.66%
EPS Next 3Y33.72%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for SNBR!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

SLEEP NUMBER CORP

NASDAQ:SNBR (2/18/2026, 10:52:34 AM)

8.58

-0.45 (-4.98%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)11-05
Earnings (Next)02-25
Inst Owners89.35%
Inst Owner Change-1.38%
Ins Owners6.63%
Ins Owner Change4.68%
Market Cap195.54M
Revenue(TTM)1.44B
Net Income(TTM)-78.11M
Analysts48.89
Price Target9.18 (6.99%)
Short Float %27.17%
Short Ratio7.26
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-915.82%
Min EPS beat(2)-937.57%
Max EPS beat(2)-894.07%
EPS beat(4)1
Avg EPS beat(4)-818.76%
Min EPS beat(4)-1452.29%
Max EPS beat(4)8.9%
EPS beat(8)3
Avg EPS beat(8)-410.77%
EPS beat(12)5
Avg EPS beat(12)-256.42%
EPS beat(16)7
Avg EPS beat(16)-175.27%
Revenue beat(2)0
Avg Revenue beat(2)-8.66%
Min Revenue beat(2)-10.05%
Max Revenue beat(2)-7.26%
Revenue beat(4)0
Avg Revenue beat(4)-6.41%
Min Revenue beat(4)-10.05%
Max Revenue beat(4)-3.11%
Revenue beat(8)1
Avg Revenue beat(8)-4.76%
Revenue beat(12)1
Avg Revenue beat(12)-4.74%
Revenue beat(16)3
Avg Revenue beat(16)-4.59%
PT rev (1m)63.64%
PT rev (3m)20%
EPS NQ rev (1m)0.5%
EPS NQ rev (3m)-3433.33%
EPS NY rev (1m)0.09%
EPS NY rev (3m)-307.58%
Revenue NQ rev (1m)-1.13%
Revenue NQ rev (3m)-2.74%
Revenue NY rev (1m)-0.21%
Revenue NY rev (3m)-3.33%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.14
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 2.62
EPS(TTM)-3.41
EYN/A
EPS(NY)-0.49
Fwd EYN/A
FCF(TTM)-2.06
FCFYN/A
OCF(TTM)-1.27
OCFYN/A
SpS63.22
BVpS-22.88
TBVpS-25.78
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -10.42%
ROE N/A
ROCE -13.07%
ROIC 3.59%
ROICexc 3.6%
ROICexgc 4.25%
OM 1.35%
PM (TTM) N/A
GM 60.05%
FCFM N/A
ROA(3y)-0.04%
ROA(5y)6.8%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)7.69%
ROIC(5y)19.87%
ROICexc(3y)7.72%
ROICexc(5y)20.02%
ROICexgc(3y)8.92%
ROICexgc(5y)24.22%
ROCE(3y)152.05%
ROCE(5y)421.6%
ROICexgc growth 3Y-45.92%
ROICexgc growth 5Y-20.82%
ROICexc growth 3Y-44.92%
ROICexc growth 5Y-20.21%
OM growth 3Y-34.99%
OM growth 5Y-18.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.42%
GM growth 5Y-0.76%
F-Score4
Asset Turnover1.92
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 7.42
Cap/Depr 31.01%
Cap/Sales 1.26%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.19
Quick Ratio 0.09
Altman-Z -0.09
F-Score4
WACC9.05%
ROIC/WACC0.4
Cap/Depr(3y)71.87%
Cap/Depr(5y)77.97%
Cap/Sales(3y)2.57%
Cap/Sales(5y)2.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-88.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1135.71%
EPS Next Y-326.51%
EPS Next 2Y20.66%
EPS Next 3Y33.72%
EPS Next 5Y34.93%
Revenue 1Y (TTM)-16.95%
Revenue growth 3Y-8.34%
Revenue growth 5Y-0.19%
Sales Q2Q%-19.63%
Revenue Next Year-17.81%
Revenue Next 2Y-10.21%
Revenue Next 3Y-5.39%
Revenue Next 5Y-3.38%
EBIT growth 1Y-36.2%
EBIT growth 3Y-40.41%
EBIT growth 5Y-18.25%
EBIT Next Year135.33%
EBIT Next 3Y53.85%
EBIT Next 5Y36.4%
FCF growth 1Y38.86%
FCF growth 3Y-75.01%
FCF growth 5Y-51.09%
OCF growth 1Y-136.39%
OCF growth 3Y-55.11%
OCF growth 5Y-32.18%

SLEEP NUMBER CORP / SNBR FAQ

What is the fundamental rating for SNBR stock?

ChartMill assigns a fundamental rating of 1 / 10 to SNBR.


What is the valuation status of SLEEP NUMBER CORP (SNBR) stock?

ChartMill assigns a valuation rating of 2 / 10 to SLEEP NUMBER CORP (SNBR). This can be considered as Overvalued.


Can you provide the profitability details for SLEEP NUMBER CORP?

SLEEP NUMBER CORP (SNBR) has a profitability rating of 3 / 10.


What is the expected EPS growth for SLEEP NUMBER CORP (SNBR) stock?

The Earnings per Share (EPS) of SLEEP NUMBER CORP (SNBR) is expected to decline by -326.51% in the next year.